相似文献
1
Editorial: Acute promyelocytic leukemia - towards a chemotherapy-free approach to cure in all patients, Volume II.
Front Oncol. 2023 Jun 27;13:1238486. doi: 10.3389/fonc.2023.1238486. eCollection 2023.
2
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
3
Editorial: Acute Promyelocytic Leukemia - Towards A Chemotherapy-Free Approach to Cure in All Patients.
Front Oncol. 2022 Jan 20;11:831308. doi: 10.3389/fonc.2021.831308. eCollection 2021.
4
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 Trial.
JAMA Oncol. 2022 Jan 1;8(1):79-87. doi: 10.1001/jamaoncol.2021.5206.
5
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
Lancet Oncol. 2018 Jul;19(7):871-879. doi: 10.1016/S1470-2045(18)30295-X. Epub 2018 Jun 5.
6
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
7
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.
Am J Health Syst Pharm. 2009 Nov 1;66(21):1913-8. doi: 10.2146/ajhp080342.
8
Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia.
Int J Hematol. 2023 Apr;117(4):530-537. doi: 10.1007/s12185-022-03507-5. Epub 2022 Dec 29.
9
Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820937008. doi: 10.1177/1533033820937008.
10
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
J Clin Oncol. 2011 Jul 10;29(20):2753-7. doi: 10.1200/JCO.2010.32.2107. Epub 2011 Jun 6.
本文引用的文献
1
Acute promyelocytic leukaemia: population-based study of epidemiology and outcome with ATRA and oral-ATO from 1991 to 2021.
BMC Cancer. 2023 Feb 10;23(1):141. doi: 10.1186/s12885-023-10612-z.
2
Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.
Toxicol Appl Pharmacol. 2022 Apr 15;441:115972. doi: 10.1016/j.taap.2022.115972. Epub 2022 Mar 9.
3
Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study.
Blood Adv. 2021 Jul 27;5(14):2829-2838. doi: 10.1182/bloodadvances.2021004789.
4
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic).
Arthritis Res Ther. 2021 Mar 3;23(1):70. doi: 10.1186/s13075-021-02454-6.
5
Second Primary Malignancy after Acute Promyelocytic Leukemia: A Population-Based Study.
Cancers (Basel). 2020 Dec 3;12(12):3610. doi: 10.3390/cancers12123610.
6
Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.
Front Oncol. 2020 Aug 4;10:1294. doi: 10.3389/fonc.2020.01294. eCollection 2020.
7
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.
Leukemia. 2020 Nov;34(11):3082-3084. doi: 10.1038/s41375-020-0905-y. Epub 2020 Jun 9.
8
Arsenic trioxide alleviates acute graft-versus-host disease by modulating macrophage polarization.
Sci China Life Sci. 2020 Nov;63(11):1744-1754. doi: 10.1007/s11427-019-1691-x. Epub 2020 May 6.
9
Oral arsenic trioxide, all-trans retinoic acid, and ascorbic acid maintenance after first complete remission in acute promyelocytic leukemia: Long-term results and unique prognostic indicators.
Cancer. 2020 Jul 15;126(14):3244-3254. doi: 10.1002/cncr.32937. Epub 2020 May 4.
10
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study.
Leukemia. 2020 Sep;34(9):2333-2341. doi: 10.1038/s41375-020-0758-4. Epub 2020 Feb 19.
Zotero 插件